Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (24)

1

Update Alert 5 : Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

enthalten in: Annals of internal medicine | 2020

von Mackey, K. | Kansagara, D. | Vela, K.

CommentOn: Ann Intern Med. 2020 Aug 4;173(3):195-203. - PMID 32422062

2

The other possible mechanism of the benefits of RAAS inhibition in the athogenesis of COVID-19

enthalten in: Clinical cardiology | 2020

von Gupta, N. | Patel, K. | Gupta, R.

CommentOn: Clin Cardiol. 2020 Aug 5;:null. - PMID 32757246

3

In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension

enthalten in: The Journal of infection | 2020

von Yuan, Y. | Liu, D. | Zeng, S. | +10

CommentOn: J Infect. 2020 Jul;81(1):e84-e86. - PMID 32283158

4

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types : implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment

enthalten in: Internal and emergency medicine | 2020

von De Cauwer, H.

CommentOn: Intern Emerg Med. 2020 Aug;15(5):759-766. - PMID 32430651

5

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types : implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply

enthalten in: Internal and emergency medicine | 2020

von Albini, A. | Noonan, D. | Pelosi, G. | +2

CommentOn: Intern Emerg Med. 2020 Nov;15(8):1581-1582. - PMID 32564289

6

Update Alert 4 : Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

enthalten in: Annals of internal medicine | 2020

von Mackey, K. | Kansagara, D. | Vela, K.

CommentOn: Ann Intern Med. 2020 Aug 4;173(3):195-203. - PMID 32422062

7

ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19

enthalten in: Journal of the American College of Cardiology | 2020

von Wang, Y. | Tse, G. | Li, G. | +2

CommentOn: J Am Coll Cardiol. 2020 Jul 21;76(3):268-276. - PMID 32470515

8

Reply : ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19

enthalten in: Journal of the American College of Cardiology | 2020

von Amat-Santos, I. | Santos-Martinez, S. | López-Otero, D. | +2

CommentOn: J Am Coll Cardiol. 2020 Oct 27;76(17):2041. - PMID 33092742

9

Update Alert 3 : Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

enthalten in: Annals of internal medicine | 2020

von Mackey, K. | Kansagara, D. | Vela, K.

CommentOn: Ann Intern Med. 2020 Aug 4;173(3):195-203. - PMID 32422062

10

Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic"

enthalten in: Diabetes & metabolic syndrome | 2020

von Ferrario, C.

CommentOn: Diabetes Metab Syndr. 2020 Jul - Aug;14(4):349-350. - PMID 32311651